Ardelyx

Ardelyx

World Rank (Aug-2026)
9194
Market Cap (Aug-2026)
1.012 Billion USD
Market Cap (Mar-08-2026)
1.518 Billion USD
World Rank (Jan-05-2024)
6,971
Market Cap (Jan-05-2024)
1.428 Billion USD
World Rank (Jul-30-2023)
9,735
Market Cap (Jul-30-2023)
0.828 Billion USD
World Rank (Jan-07-2022)
22,233
Market Cap (Jan-07-2022)
0.113 Billion USD
World Rank (Jan-01-2021)
10,269
Market Cap (Jan-01-2021)
0.604 Billion USD
Headquarters Country
USA
Nasdaq / NYSE Code
ARDX
Headquarters City/State
California
World Region
Americas
World Subregion
Northern America
Annual Revenue in USD
407 Million USD
Annual Operating Income in USD
-41 Million USD
Annual Net Income in USD
-62 Million USD
Annual Results for Period Ending
For year ending December-2025
Total Assets in USD
502 Million USD
Total Liabilities in USD
335 Million USD
Total Equity in USD
167 Million USD
Balance Sheet for Period Ending
As of December-2025
Business Sector
Healthcare
HealthCare Products
Biotechnology
Company Website
ARDELYX
Yahoo
Yahoo @ Frankfurt
Company Profile

Ardelyx is a Biotechnology company enabled to develop a pipeline of drug candidates designed to better manage complications related to kidney and cardiorenal diseases. The headquarters is in USA.

Facts About Company

Ardelyx Annual Total Revenue for year ending Dec-2022 was 52 million USD and and Net loss for year ending Dec-2022 was -67 million USD.

Ardelyx Annual Total Revenue for year ending Dec-2021 was 10 million USD and and Net loss for year ending Dec-2021 was -158 million USD.

As on 2022, Ardelyx has 133 employees.

Founded Year
2007
IPO Year
2014
Stock Exchange
Nasdaq
Frankfurt
Nasdaq Sector
Health Care
Nasdaq Industry
Biotechnology: Pharmaceutical Preparations

Share